INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
Sponsor: Inovio Pharmaceuticals
A PHASE1/PHASE2 clinical study on Glioblastoma, this trial is ongoing. The trial is conducted by Inovio Pharmaceuticals and has accumulated 52 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
52 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Dec 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Nov 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Oct 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
▶ Show 47 earlier versions
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jun 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Nov 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2023 — Jun 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2022 — Mar 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2018 — Jul 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Inovio Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .